MétaCan
Menu
← Back to cohort

Differences in uptake of postoperative adjuvant chemotherapy for lung cancer: Results from the Project for an Ontario Women's Health Evidence-Based Report Card (POWER) study

2009· article· en· W2247903747 on OpenAlexaffabout
Lisa Barbera, Monika K. Krzyzanowska, L. Elit, Refik Saskin, Arlene S. Bierman

Bibliographic record

VenueJournal of Clinical Oncology · 2009
Typearticle
Languageen
FieldMedicine
TopicGlobal Cancer Incidence and Screening
Canadian institutionsPrincess Margaret Cancer CentreJuravinski Cancer Centre
Fundersnot available
KeywordsMedicineChemotherapyLung cancerCancer registryAdjuvant chemotherapyCohortInternal medicineCancerOncologySurgeryBreast cancer

Abstract

fetched live from OpenAlex

6556 Background: The goal of the POWER study is to improve health and reduce inequities among women of Ontario using performance measurement. Indicators are selected to facilitate assessment of care by sex and neighbourhood income. Results pertaining to the uptake of postoperative adjuvant chemotherapy for non-small cell lung cancer (NSCLC) are presented. Methods: An expert panel process was used to identify performance measures feasible to be evaluated from administrative data. Recent evidence suggests that adjuvant chemotherapy after resection of NSCLC is associated with improved survival. This measure was selected the by the expert panel. Data from Ontario Cancer Registry, Registered Persons Database as well as provincial billing and hospital databases was used to evaluate this measure stratified by age, sex, income and region. All adult patients who underwent resection of NSCLC between April 2003 and May 2004 were included in the cohort. Claims indicating chemotherapy administration within 6 months of surgery were considered adjuvant chemotherapy. Results: Overall in Ontario, the use of postoperative chemotherapy in NSCLC was 17.6% (95% CI 15.3%-20.2%) in April 2003 increasing to 32.9% (95%CI 29.8%-36.3%) in May 2004. In May 2004. use of chemotherapy decreased with increasing age: 47% of patients <65 years received chemotherapy versus 27% of patients aged 65–79. There was significant variation by region: in those under 65 years the rate of chemotherapy use among 14 regions ranged between 24–70 percent; in those 65–79 years it ranged between 18–35 percent. There was no difference in chemotherapy use between men or women or by neighbourhood income quintile. Conclusions: Rates of chemotherapy use almost doubled from April 2003 to May 2004, suggesting uptake of the new evidence in the treating community. Age and region-related, rather than sex or income, differences exist in the uptake of this new evidence. Further work is necessary to determine how these differences in uptake affect outcomes. No significant financial relationships to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.007
metaresearch head score (Gemma)0.019
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.984
Threshold uncertainty score0.136

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0070.019
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.005
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.410
GPT teacher head0.557
Teacher spread0.148 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2009
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicGlobal Cancer Incidence and Screening→French-language works237,207→